G üvendik G, G ü n d ü zer S, Tümtürk N. M eslekleri n ed en i ile karbo n m o n ok site m a ru z k a la n itfaiye erlerin de k a n d a karb ok sih em og lo b in düzeyi.A dli Tıp B ü lten i 1 9 9 7 ;2 (1): 7-10.
SUMMARYVarious epidemiological and clinical researches have been carried out in order to find out the relationship between selenium deficiency and other diseases, mainly cardiovascular diseases and certain types of cancer. In this study, we have aimed at determining serum selenium levels of the patients with acute myocardial infarction (A. M.I.), coronary artery disease (C.A.D), and the healthy control group, and investigating whether there are any significant differences between the serum selenium levels of the healthy control group and the patients with A.M.I, and C.A.D. Mean serum selenium levels were found to be 38.59 ± 15.25 / L in the patients (n=22) with acute myocardial infarction, 37.20 ±11.44 / L in the patients (n = 27) with coronary artery disease, and 63.66 ± 11.71 / L in the healthy control group (n = 21). There was no significant difference between mean serum selenium levels of the patients with A.M.I, and C.A.D (p>0.05), but significant differences have been found between the mean serum selenium levels of the healthy control group and the other two groups mentioned above. (p<0.01) Selenyum eksikliği ile başta kardiovasküler hastalıklar ve kanser olmak üzere çeşitli hastalıklar arasındaki ilişkiyi ortaya koyan çeşitli epidemiyolojik ve klinik çalışmalar bulunmaktadır.Bu çalışmada akut miyokard infarktüslü ve koroner arter hastalığı olan hastalarda serum selenyum düzeylerinin tayini ve sağlıklı kont-ÖZET Redaksiyona verildiği tarih: 22.6.1993
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.